Skip to main content

Articles

FDA Approvals
The Hematology Pipeline Is Abundant
Read More
Value and Cost-Effectiveness Analyses Should Be Included in Reimbursement Decisions
Read More
Leukemia, Oncology
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Read More
FDA Approvals, Payers' Guide
The Sixth Annual Payers’ Guide to New FDA Approvals
Read More
Introduction, Payers' Guide
New FDA Drug Approvals Hit an 18-Year High in 2014
Read More
Payers' Guide, FDA Approvals
FDA Approvals of Brand-Name Prescription Drugs in 2014
Read More
Payers' Guide, FDA Approvals
Afrezza (Insulin Human) Inhalation Powder Approved for the Treatment of Patients with Type 1 or Type 2 Diabetes
Read More
Payers' Guide, FDA Approvals
Akynzeo (Netupitant and Palonosetron), a Dual-Acting Oral Agent, Approved by the FDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Read More
Payers' Guide, FDA Approvals
Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non–Small-Cell Lung Cancer
Read More
Payers' Guide, FDA Approvals
Once-a-Day Harvoni (Ledipasvir plus Sofosbuvir), a New Oral Combination for the Treament of Patients with Genotype 1 Chronic Hepatitis C Infection
Read More
Page 136 of 245
Results 1351 - 1360 of 2441